Matches in Nanopublications for { ?s ?p "[We compared gene expression in CD34+ cells from patients who developed t-MDS/AML after autologous hematopoietic cell transplantation (aHCT) for lymphoma with controls who did not develop t-MDS/AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 15 of
15
with 100 items per page.
- NP605968.RASybJBCelMnFiLnAiUXemNMwqvzsXfD5o5j8mlbfNHlE130_assertion description "[We compared gene expression in CD34+ cells from patients who developed t-MDS/AML after autologous hematopoietic cell transplantation (aHCT) for lymphoma with controls who did not develop t-MDS/AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605968.RASybJBCelMnFiLnAiUXemNMwqvzsXfD5o5j8mlbfNHlE130_provenance.
- NP873173.RAREee2KQOL89qowvcpU92uQe0ruDE5HC84g-Clb0rGuM130_assertion description "[We compared gene expression in CD34+ cells from patients who developed t-MDS/AML after autologous hematopoietic cell transplantation (aHCT) for lymphoma with controls who did not develop t-MDS/AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873173.RAREee2KQOL89qowvcpU92uQe0ruDE5HC84g-Clb0rGuM130_provenance.
- NP978509.RAcXZmR4jBer9-75WHbJD1L63hsnDhcu8LdhENhf6F4cM130_assertion description "[We compared gene expression in CD34+ cells from patients who developed t-MDS/AML after autologous hematopoietic cell transplantation (aHCT) for lymphoma with controls who did not develop t-MDS/AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978509.RAcXZmR4jBer9-75WHbJD1L63hsnDhcu8LdhENhf6F4cM130_provenance.
- assertion description "[We compared gene expression in CD34+ cells from patients who developed t-MDS/AML after autologous hematopoietic cell transplantation (aHCT) for lymphoma with controls who did not develop t-MDS/AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We compared gene expression in CD34+ cells from patients who developed t-MDS/AML after autologous hematopoietic cell transplantation (aHCT) for lymphoma with controls who did not develop t-MDS/AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We compared gene expression in CD34+ cells from patients who developed t-MDS/AML after autologous hematopoietic cell transplantation (aHCT) for lymphoma with controls who did not develop t-MDS/AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We compared gene expression in CD34+ cells from patients who developed t-MDS/AML after autologous hematopoietic cell transplantation (aHCT) for lymphoma with controls who did not develop t-MDS/AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP939583.RAR3pulEmM2pAgLZFZIT2fvlZF2osUK4NrUfxvi4e0nwY130_assertion description "[We compared gene expression in CD34+ cells from patients who developed t-MDS/AML after autologous hematopoietic cell transplantation (aHCT) for lymphoma with controls who did not develop t-MDS/AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP939583.RAR3pulEmM2pAgLZFZIT2fvlZF2osUK4NrUfxvi4e0nwY130_provenance.
- NP939589.RAZWpJ6iq6kA-Unz09-k_1UveZiSsNouf1H2BZ8vHssmw130_assertion description "[We compared gene expression in CD34+ cells from patients who developed t-MDS/AML after autologous hematopoietic cell transplantation (aHCT) for lymphoma with controls who did not develop t-MDS/AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP939589.RAZWpJ6iq6kA-Unz09-k_1UveZiSsNouf1H2BZ8vHssmw130_provenance.
- NP939590.RAT4gibHDG_Y5upgZjeFblsXxO1E9l8tJDLSiL745HQUA130_assertion description "[We compared gene expression in CD34+ cells from patients who developed t-MDS/AML after autologous hematopoietic cell transplantation (aHCT) for lymphoma with controls who did not develop t-MDS/AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP939590.RAT4gibHDG_Y5upgZjeFblsXxO1E9l8tJDLSiL745HQUA130_provenance.
- NP781413.RAvUpWS7ugWlLlGFJjxHThtKVe39spwDgSwbg9aKcKGo8130_assertion description "[We compared gene expression in CD34+ cells from patients who developed t-MDS/AML after autologous hematopoietic cell transplantation (aHCT) for lymphoma with controls who did not develop t-MDS/AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781413.RAvUpWS7ugWlLlGFJjxHThtKVe39spwDgSwbg9aKcKGo8130_provenance.
- assertion description "[We compared gene expression in CD34+ cells from patients who developed t-MDS/AML after autologous hematopoietic cell transplantation (aHCT) for lymphoma with controls who did not develop t-MDS/AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP913999.RAHHl5KV8W_3feAZtV6scqbAq8XS9J_7UwcSPqmEOFLzk130_assertion description "[We compared gene expression in CD34+ cells from patients who developed t-MDS/AML after autologous hematopoietic cell transplantation (aHCT) for lymphoma with controls who did not develop t-MDS/AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913999.RAHHl5KV8W_3feAZtV6scqbAq8XS9J_7UwcSPqmEOFLzk130_provenance.
- NP939581.RANkBFGWa4YnogSSWavDY0nqsvkKKb_O13t6nvnT5sVsM130_assertion description "[We compared gene expression in CD34+ cells from patients who developed t-MDS/AML after autologous hematopoietic cell transplantation (aHCT) for lymphoma with controls who did not develop t-MDS/AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP939581.RANkBFGWa4YnogSSWavDY0nqsvkKKb_O13t6nvnT5sVsM130_provenance.
- NP939582.RA3WwEGJlJ9znR31u_i2c-Qj2ykyRvED0ND4xIBA_eWzY130_assertion description "[We compared gene expression in CD34+ cells from patients who developed t-MDS/AML after autologous hematopoietic cell transplantation (aHCT) for lymphoma with controls who did not develop t-MDS/AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP939582.RA3WwEGJlJ9znR31u_i2c-Qj2ykyRvED0ND4xIBA_eWzY130_provenance.